How Supercharged Immune Cells Could Transform Biotech SMEs
Supercharged immune cells erased solid tumors in mice, experimentally validating a biotech stack that could reshape medicine, startups, and cyberpunk commerce. Discover how metabolic tweaks, in situ cell generation, and delivery modules invite new product models, regulatory peril, and elite augmentation markets. Read the analysis on risks, costs, and strategy.
